Fatima Ezzahra Errachidi*
Alzheimer's disease is one of the most common neurodegenerative disorders that affects millions globally. It is characterized by loss of neurons, neurofibrillary tangles, and beta-amyloid accumulation, however, the mechanism behind these pathological features is still unclear. Recently, increasing evidence demonstrates the role of the meningeal lymphatic system (MLS) in cerebrospinal fluid (CSF) transportation, beta-amyloid clearance, and neuroinflammation. Thus, MLS may be considered a potential therapeutic target for neurodegenerative diseases. Here, we discuss the multiple functions of the meningeal lymphatic system and its potential role in the progression of Alzheimer's disease.
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi